Training purpose selection is required.
Training plan selection is required.
Participants who complete this course will receive 0.5 PACE Contact Hours.
bioMérieux Inc. is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program
Instructions:
This course is divided into three sections, which must be completed in sequence.
- Course Content
- Knowledge Assessment with a passing score of 80%
- Course evaluation (Survey)
Overview:
Dr. Lasco will discuss the public health threat that antimicrobial resistance (AMR) poses, in general, highlighting the utility of antibiotics, temporal patterns of antimicrobial resistance, drivers of AMR, and share AMR forecasts in terms of its impact on morbidity/mortality as well as its economic impact. In addition, AMR “priority” pathogens and the emerging role of the clinical microbiology laboratory in characterizing AMR in clinical isolates (both traditional and emerging technologies) will be discussed. Lastly, a description of antimicrobial stewardship and its role in the management of AMR, and where the microbiology laboratory management fits into this organizational structure will be provided.
Objectives:
At the end of this session, you will be able to:
- Discuss the threat of antimicrobial resistance (AMR)
- Describe the emerging role of the clinical microbiology laboratory in characterizing AMR in clinical isolates
- Describe antimicrobial stewardship and the emerging role of the clinical microbiology laboratory in managing AMR
Speaker:
Dr. Todd M. Lasco
PhD, D (ABMM)
Level of Instruction: Intermediate
Let's get started!